| Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 L Bedenne, P Michel, O Bouché, C Milan, C Mariette, T Conroy, D Pezet, ... Journal of clinical oncology 25 (10), 1160-1168, 2007 | 1422 | 2007 |
| Gut microbiota imbalance and colorectal cancer J Gagnière, J Raisch, J Veziant, N Barnich, R Bonnet, E Buc, MA Bringer, ... World journal of gastroenterology 22 (2), 501, 2016 | 793 | 2016 |
| Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA AR Thierry, F Mouliere, S El Messaoudi, C Mollevi, E Lopez-Crapez, ... Nature medicine 20 (4), 430-435, 2014 | 724 | 2014 |
| Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901 C Mariette, L Dahan, F Mornex, E Maillard, PA Thomas, B Meunier, ... J Clin Oncol 32 (23), 2416-2422, 2014 | 623 | 2014 |
| Hybrid minimally invasive esophagectomy for esophageal cancer C Mariette, SR Markar, TS Dabakuyo-Yonli, B Meunier, D Pezet, D Collet, ... New England Journal of Medicine 380 (2), 152-162, 2019 | 574 | 2019 |
| High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer E Buc, D Dubois, P Sauvanet, J Raisch, J Delmas, A Darfeuille-Michaud, ... PloS one 8 (2), e56964, 2013 | 506 | 2013 |
| Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre … F Quénet, D Elias, L Roca, D Goéré, L Ghouti, M Pocard, O Facy, ... The Lancet Oncology 22 (2), 256-266, 2021 | 471 | 2021 |
| Colonization of the Human Gut by E. coli and Colorectal Cancer Risk M Bonnet, E Buc, P Sauvanet, C Darcha, D Dubois, B Pereira, ... Clinical Cancer Research 20 (4), 859-867, 2014 | 432 | 2014 |
| Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype A Cougnoux, G Dalmasso, R Martinez, E Buc, J Delmas, L Gibold, ... Gut 63 (12), 1932-1942, 2014 | 430 | 2014 |
| Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with … E Gamelin, R Delva, J Jacob, Y Merrouche, JL Raoul, D Pezet, E Dorval, ... Journal of clinical oncology 26 (13), 2099-2105, 2008 | 413 | 2008 |
| A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7 F Quenet, D Elias, L Roca, D Goere, L Ghouti, M Pocard, O Facy, ... J Clin Oncol 36 (18 Suppl), 3503, 2018 | 375 | 2018 |
| Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial E Rullier, P Rouanet, JJ Tuech, A Valverde, B Lelong, M Rivoire, ... The Lancet 390 (10093), 469-479, 2017 | 345 | 2017 |
| Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review N Kerckhove, A Collin, S Condé, C Chaleteix, D Pezet, D Balayssac Frontiers in pharmacology 8, 86, 2017 | 326 | 2017 |
| Management of splenic artery aneurysms and false aneurysms with endovascular treatment in 12 patients R Guillon, JM Garcier, A Abergel, R Mofid, V Garcia, T Chahid, A Ravel, ... Cardiovascular and interventional radiology 26, 256-260, 2003 | 255 | 2003 |
| Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer D Melisi, R Garcia-Carbonero, T Macarulla, D Pezet, G Deplanque, ... British journal of cancer 119 (10), 1208-1214, 2018 | 227 | 2018 |
| Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses MC Etienne, M Chazal, P Laurent-Puig, N Magné, C Rosty, JL Formento, ... Journal of clinical oncology 20 (12), 2832-2843, 2002 | 227 | 2002 |
| Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised … CS Fuchs, K Shitara, M Di Bartolomeo, S Lonardi, SE Al-Batran, ... The Lancet Oncology 20 (3), 420-435, 2019 | 226 | 2019 |
| The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study M Messager, JH Lefevre, V Pichot-Delahaye, A Souadka, G Piessen, ... Annals of surgery 254 (5), 684-693, 2011 | 216 | 2011 |
| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 198 | 2023 |
| Endoscopic ultrasound-guided biliary drainage after failed ERCP: cumulative experience of 101 procedures at a single center L Poincloux, O Rouquette, E Buc, J Privat, D Pezet, M Dapoigny, ... Endoscopy, 794-801, 2015 | 198 | 2015 |
